Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. 6, 2022– Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company...
Events, News, Presentations
Virtual KOL Event: Discussion of STRO-002 Interim Dose Expansion Cohort Data – Presentation Webcast, Jan 5, 2022 at 5:00pm EST...
Events, News, Presentations, Press Releases
Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer – Dr. Naumann and Sutro management to discuss interim data on the STRO-002 Phase 1...
Events, News, Presentations
4th Annual Evercore ISI HeathCONx Conference – Presentation Webcast, Nov 30, 2021 at 10:05am EST Download Presentation, Click...